Navigation Links
Industry Experts and Global Regulators to Discuss Oligonucleotide-Based Therapeutics Issues
Date:8/15/2008

The Drug Information Association (DIA), in collaboration with the FDA, Oligonucleotide Therapeutics Society, Health Canada, and the American Association of Pharmaceutical Scientists, will host the 2nd Conference on Oligonucleotide-based Therapeutics (September 22 - 24; Falls Church, VA).

Horsham, PA (PRWEB) August 15, 2008 -- The http://www.diahome.org/ [Drug Information Association (DIA)]], in collaboration with the FDA, Oligonucleotide Therapeutics Society, Health Canada, and the American Association of Pharmaceutical Scientists, will host the http://www.diahome.org/DIAHOME/Education/FindEducationalOffering.aspx?productID=14730&eventType=Meeting [2nd Conference on Oligonucleotide-based Therapeutics] (September 22 - 24; Falls Church, VA).

"Attendees can share product development and regulatory information in the areas of nonclinical, chemistry, manufacturing and control (CMC), and clinical development of Oligonucleotide-based therapeutic drugs with industry experts and international regulators," says Program Co-chair David H. Schubert, Vice President of Regulatory Affairs, Logical Therapeutics, Inc.

Sessions will discuss:

  • siRNAs
  • Non-Hybridization Dependent Oligonucleotides
  • Antisense Oligonucleotide Discovery and Development
  • Emerging Oligonucleotide Issues
  • Starting Materials and GMP Synthesis
  • Formulations and GMP
  • Establishing Proof of Structure
  • Stability of Drug Substance and Drug Product
  • Novel Chemistry
  • Clinical Applications of siRNAs
  • Clinical Opportunities for Manipulating MicroRNAs Pathways
  • Clinical applications of Antisense Oligonucleotides
  • Clinical Applications of Aptamers
  • Clinical Opportunities for Immunostimulatory Oligonucleotides
  • Delivery of Oligonucleotides

Keynote speakers will include Craig C. Mello, PhD, University of Mass Medical School and 2006 Nobel Laureate, and Alan B. Sachs, MD, PhD, Merck Research Laboratories.

The final day will feature a panel discussion with representatives from the EMEA, FDA, Health Canada and PMDA.

About the www.diahome.org [Drug Information Association (DIA)]
DIA serves more than 30,000 professionals in the biotechnology, pharmaceutical and regulatory industries worldwide. Through its domestic and international meetings, training courses, workshops and webinars, DIA provides a neutral global forum for the exchange of information critical to the advancement of the drug discovery and lifecycle management processes. Headquartered in Horsham, PA, USA, and with offices in Basel, Switzerland, Tokyo, Japan, and Mumbai, India, the Association is led by its volunteer-based Board of Directors and executive management team. For more information, visit www.diahome.org or call 215-442-6100.

Contact:
Joe Krasowski
215-293-5812
Joe.Krasowski @ diahome.org

# # #

Read the full story at http://www.prweb.com/releases/Oligonucleotide-Based/Therapeutics/prweb1213554.htm


'/>"/>
Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved

Related medicine news :

1. Shamir Optical Industry Ltd. to Host Conference Call Announcing Second Quarter 2008 Earnings Results
2. ChemBridge Research Laboratories, Inc. (CRL) has Established an Industry Record and Benchmark in Hit-to-Lead Libraries Turn-around Time
3. Anthem Blue Cross and Blue Shield in Colorado Introduces Industry Leading and Comprehensive Transparency Initiative to Colorado
4. Connextions Cited in Leading Industry Analyst Firm's "Hype Cycle" For Health Care Provider Marketing Applications
5. REHACARE INTERNATIONAL 2008: Platform for Rehabilitation Industry
6. Southern Home Medicals Encore Medical Staffing Division Poised to Benefit from Major Growth in Nursing Industry
7. R&D and Regulatory Leaders in the Cosmetics/Personal Care Field Present Latest Industry Research at HBA Global Expo
8. Eularis Analyzes Most Effective Generics Defense Strategies With New Pharmaceutical Industry Report
9. Entertainment Industry Foundation Unites Major Studios and State of California for Historic Anti-Smoking Campaign
10. Advisory: Entertainment Industry Foundation, Gov. Schwarzenegger to Announce Major Hollywood Anti-Smoking Initiative
11. Lilly Supports Industry Code on Interactions with Healthcare Professionals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... ... January 19, 2017 , ... Sam & Associates Insurance ... commercial and residential clients in the California Bay Area, is launching a charity drive ... the region. , Heart disease is the primary killer of adult men and women ...
(Date:1/19/2017)... ... January 19, 2017 , ... Attorney Robert “RC” Pate ... year donated money to the Triumph Over Kid Cancer foundation. Each year, 175,000 children ... those children. James saw firsthand the effect of the critical funding gap for research ...
(Date:1/19/2017)... ... ... Connecticut Dermatology Group (CDG) is proud and excited to welcome back to ... Kim brings an extensive background in cutting-edge dermatology care and research to Connecticut’s largest ... Dr. Kim to the CDG team” said President and Managing Partner Dr. Steven A. ...
(Date:1/19/2017)... Atlanta, Georgia (PRWEB) , ... January 19, 2017 ... ... Reconstructive Surgeons hosts the Atlanta Breast Surgery Symposium, a conference where hundreds of ... latest advancements in breast surgery. Covering topics from cosmetic breast augmentation ...
(Date:1/18/2017)... , ... January 18, 2017 , ... From a health ... released almost daily linking gut health to chronic disease, mental health and general physical ... ” as an important resolution to consider. , For one Charlottesville restaurant, good gut ...
Breaking Medicine News(10 mins):
(Date:1/18/2017)... SAINT PAUL, Minn. , Jan. 18, 2017 ... the developer of medical devices using neuroblocking technology ... disorders, today announced the pricing of an underwritten ... $16.5 million, prior to deducting underwriting discounts and ... The offering is comprised of Class A ...
(Date:1/18/2017)... -- Adaptive Sound Technologies, Inc. (ASTI), the leading supplier of ... Place Nashville/Downtown to deliver the best sleep experience for ... in over two hundred of its guest rooms. ... having a great stay is sleeping well," said ... "We,re pleased to be able to offer our guests ...
(Date:1/18/2017)... SAN DIEGO , Jan. 18, 2017 /PRNewswire/ ... and innovative products to treat a variety of ... its lead compound DMT210, in a Phase 2 ... specifically developed to downregulate the proinflammatory cytokines in ... seen in acne rosacea. This ...
Breaking Medicine Technology: